Transforming growth factor α-dependent cancer progression is modulated by Muc1

Mamata R. Pochampalli, Benjamin G. Bitler, Joyce Schroeder

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Transforming growth factor α (TGFα) is a potent inducer of cellular transformation, through its binding and activation of the epidermal growth factor receptor (EGFR). Previous studies in our laboratory showed that EGFR could also be affected by the glycoprotein MUC1, which inhibits ligand-stimulated degradation of EGFR in breast epithelial cell lines. To determine the effect of Muc1 expression on TGFα/EGFR-dependent breast transformation, we crossed the WAP-TGFα transgenic mouse model of breast cancer onto a Muc1-null background. We found that the loss of Muc1 expression dramatically affects mammary gland transformation and progression. Although 100% of WAP-TGFα/Muc1+/+ mice form mammary gland tumors by 1 year, only 37% of WAP-TGFAα/Muc1-/- form tumors by this time. This difference is also associated with a delay in onset, with a doubling of onset time observed in the WAP-TGFα/Muc1-/- compared with the WAP-TGFα/Muc1+/+ mice. Analysis of signal transduction pathways revealed that activation of cyclin D1 expression is significantly suppressed in tumors derived from WAP-TGFα/Muc1-/- animals compared with those expressing Muc1. The loss of Muc1 expression also results in a significant inhibition in the formation of hyperplastic lesions during tumor progression. On the C57Bl/6 inbred background, pulmonary lesions were observed in 28 of 29 WAP-TGFα/Muc1+/+ animals (including one metastatic pulmonary adenocarcinoma and multiple perivascular lymphomas), although none were detected in the WAP-TGFα/Muc1-/- animals. Together, these data indicate that Muc1 is an important modulator of TGFα-dependent tumor progression.

Original languageEnglish (US)
Pages (from-to)6591-6598
Number of pages8
JournalCancer Research
Volume67
Issue number14
DOIs
StatePublished - Jul 15 2007

Fingerprint

Transforming Growth Factors
Neoplasms
Epidermal Growth Factor Receptor
Human Mammary Glands
Breast
Breast Neoplasms
Cyclin D1
Transgenic Mice
Signal Transduction
Lymphoma
Glycoproteins
Epithelial Cells
Ligands
Cell Line
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Transforming growth factor α-dependent cancer progression is modulated by Muc1. / Pochampalli, Mamata R.; Bitler, Benjamin G.; Schroeder, Joyce.

In: Cancer Research, Vol. 67, No. 14, 15.07.2007, p. 6591-6598.

Research output: Contribution to journalArticle

Pochampalli, Mamata R. ; Bitler, Benjamin G. ; Schroeder, Joyce. / Transforming growth factor α-dependent cancer progression is modulated by Muc1. In: Cancer Research. 2007 ; Vol. 67, No. 14. pp. 6591-6598.
@article{b1a8ffc1d201497b8ad134ef331fdcde,
title = "Transforming growth factor α-dependent cancer progression is modulated by Muc1",
abstract = "Transforming growth factor α (TGFα) is a potent inducer of cellular transformation, through its binding and activation of the epidermal growth factor receptor (EGFR). Previous studies in our laboratory showed that EGFR could also be affected by the glycoprotein MUC1, which inhibits ligand-stimulated degradation of EGFR in breast epithelial cell lines. To determine the effect of Muc1 expression on TGFα/EGFR-dependent breast transformation, we crossed the WAP-TGFα transgenic mouse model of breast cancer onto a Muc1-null background. We found that the loss of Muc1 expression dramatically affects mammary gland transformation and progression. Although 100{\%} of WAP-TGFα/Muc1+/+ mice form mammary gland tumors by 1 year, only 37{\%} of WAP-TGFAα/Muc1-/- form tumors by this time. This difference is also associated with a delay in onset, with a doubling of onset time observed in the WAP-TGFα/Muc1-/- compared with the WAP-TGFα/Muc1+/+ mice. Analysis of signal transduction pathways revealed that activation of cyclin D1 expression is significantly suppressed in tumors derived from WAP-TGFα/Muc1-/- animals compared with those expressing Muc1. The loss of Muc1 expression also results in a significant inhibition in the formation of hyperplastic lesions during tumor progression. On the C57Bl/6 inbred background, pulmonary lesions were observed in 28 of 29 WAP-TGFα/Muc1+/+ animals (including one metastatic pulmonary adenocarcinoma and multiple perivascular lymphomas), although none were detected in the WAP-TGFα/Muc1-/- animals. Together, these data indicate that Muc1 is an important modulator of TGFα-dependent tumor progression.",
author = "Pochampalli, {Mamata R.} and Bitler, {Benjamin G.} and Joyce Schroeder",
year = "2007",
month = "7",
day = "15",
doi = "10.1158/0008-5472.CAN-06-4518",
language = "English (US)",
volume = "67",
pages = "6591--6598",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Transforming growth factor α-dependent cancer progression is modulated by Muc1

AU - Pochampalli, Mamata R.

AU - Bitler, Benjamin G.

AU - Schroeder, Joyce

PY - 2007/7/15

Y1 - 2007/7/15

N2 - Transforming growth factor α (TGFα) is a potent inducer of cellular transformation, through its binding and activation of the epidermal growth factor receptor (EGFR). Previous studies in our laboratory showed that EGFR could also be affected by the glycoprotein MUC1, which inhibits ligand-stimulated degradation of EGFR in breast epithelial cell lines. To determine the effect of Muc1 expression on TGFα/EGFR-dependent breast transformation, we crossed the WAP-TGFα transgenic mouse model of breast cancer onto a Muc1-null background. We found that the loss of Muc1 expression dramatically affects mammary gland transformation and progression. Although 100% of WAP-TGFα/Muc1+/+ mice form mammary gland tumors by 1 year, only 37% of WAP-TGFAα/Muc1-/- form tumors by this time. This difference is also associated with a delay in onset, with a doubling of onset time observed in the WAP-TGFα/Muc1-/- compared with the WAP-TGFα/Muc1+/+ mice. Analysis of signal transduction pathways revealed that activation of cyclin D1 expression is significantly suppressed in tumors derived from WAP-TGFα/Muc1-/- animals compared with those expressing Muc1. The loss of Muc1 expression also results in a significant inhibition in the formation of hyperplastic lesions during tumor progression. On the C57Bl/6 inbred background, pulmonary lesions were observed in 28 of 29 WAP-TGFα/Muc1+/+ animals (including one metastatic pulmonary adenocarcinoma and multiple perivascular lymphomas), although none were detected in the WAP-TGFα/Muc1-/- animals. Together, these data indicate that Muc1 is an important modulator of TGFα-dependent tumor progression.

AB - Transforming growth factor α (TGFα) is a potent inducer of cellular transformation, through its binding and activation of the epidermal growth factor receptor (EGFR). Previous studies in our laboratory showed that EGFR could also be affected by the glycoprotein MUC1, which inhibits ligand-stimulated degradation of EGFR in breast epithelial cell lines. To determine the effect of Muc1 expression on TGFα/EGFR-dependent breast transformation, we crossed the WAP-TGFα transgenic mouse model of breast cancer onto a Muc1-null background. We found that the loss of Muc1 expression dramatically affects mammary gland transformation and progression. Although 100% of WAP-TGFα/Muc1+/+ mice form mammary gland tumors by 1 year, only 37% of WAP-TGFAα/Muc1-/- form tumors by this time. This difference is also associated with a delay in onset, with a doubling of onset time observed in the WAP-TGFα/Muc1-/- compared with the WAP-TGFα/Muc1+/+ mice. Analysis of signal transduction pathways revealed that activation of cyclin D1 expression is significantly suppressed in tumors derived from WAP-TGFα/Muc1-/- animals compared with those expressing Muc1. The loss of Muc1 expression also results in a significant inhibition in the formation of hyperplastic lesions during tumor progression. On the C57Bl/6 inbred background, pulmonary lesions were observed in 28 of 29 WAP-TGFα/Muc1+/+ animals (including one metastatic pulmonary adenocarcinoma and multiple perivascular lymphomas), although none were detected in the WAP-TGFα/Muc1-/- animals. Together, these data indicate that Muc1 is an important modulator of TGFα-dependent tumor progression.

UR - http://www.scopus.com/inward/record.url?scp=34547119309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547119309&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-4518

DO - 10.1158/0008-5472.CAN-06-4518

M3 - Article

C2 - 17638868

AN - SCOPUS:34547119309

VL - 67

SP - 6591

EP - 6598

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 14

ER -